Searched for
GSK PHARMACEUTICALS
BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...28 Jul, 2026, 11.49 PM IST- AstraZeneca 'magic' faces rare test after trial failure, share slideAstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...24 Jul, 2026, 11.56 AM IST
- Global Market: Cerebras bets big on Europe with AI infrastructure expansion amid soaring demandCerebras is significantly increasing its European AI computing capacity. The company plans to reach 200 megawatts by next year. This expans...09 Jul, 2026, 03.38 PM IST
- $10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...10 Jun, 2026, 01.06 AM IST
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...27 Aug, 2022, 10.12 AM IST
- Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capabili...23 Jun, 2019, 11.57 AM IST
- GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...10 Mar, 2014, 04.04 PM IST
- $1 billion bet: GSK Pharma a short-term sell, long-term buy, say expertsThe stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.16 Dec, 2013, 04.28 PM IST
- No major surprise on GSK Pharma offer: Dipen ShanGSK, which holds 50.7 per cent stake, wants to raise up to 75 per cent at a price of Rs 3,100 a share.16 Dec, 2013, 12.59 PM IST
- GSK Pharma rallies 20% as parent initiates open offerThe parent of GlaxoSmithKline Pharmaceuticals Ltd plans to increase its stake from 50.7 per cent to up to 75 per cent at an offer price of ...16 Dec, 2013, 09.47 AM IST
- GlaxoSmithKline Pharmaceuticals Q3 net up 4.44% at Rs 152.34 croreGlaxoSmithKline today reported 4.44 per cent rise in net profit at Rs 152.34 crore for the quarter ended September 30, 2012 on back of robu...09 Nov, 2012, 03.05 PM IST
- GlaxoSmithKline Pharma Q3 net dips 7.57% to Rs 145.86 crGSK Pharmaceuticals today reported 7.57 per cent decline in net profit for the third quarter ended September 30, 2011 to Rs 145.86 crore.04 Nov, 2011, 06.26 PM IST
- Glaxo to step up capacity for elephantiasis drug productionBritish drugmaker GlaxoSmithKline (GSK) will increase its capacity to make a drug for the treatment of elephantiasis at its manufacturing f...15 Oct, 2010, 02.33 AM IST
- GSK to lower prices to woo India mktGlaxoSmithKline CEO Andrew Witty says the pharma major plans to invest Rs 430 crore to develop vaccines here.10 Mar, 2010, 01.23 AM IST
- DRL, GSK ink pact to develop, market genericsDr Reddy’s Laboratories (DRL) has partnered with GlaxoSmithKline (GSK) to develop and market generics and formulations in emerging markets ...16 Jun, 2009, 03.13 AM IST
- Pharma cos may face penalties for overpricingDrugmakers, such as Dr Reddy’s Laboratories, Wyeth, GlaxoSmithKline (GSK) Pharmaceuticals and Alkem Laboratories, may now have to face stat...24 Feb, 2009, 02.19 AM IST
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...05 May, 2008, 10.08 PM IST
Load More
